Skip to main content

BRIEF-Achillion announces clinical milestone for the advancement of JNJ-4178

* Achillion announces clinical milestone for the advancement of JNJ-4178 in phase 2B development for chronic HCV
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.